Hospital
South Coast Global Medical Center, INC
South Coast Global Medical Center, INC was paid $3.98M by Medicaid between Jan 2018 and Dec 2024, across 146 billing codes. Its largest line is 0450, Emergency room services — 13% of everything it billed.
33Billing provider infoSOUTH COAST GLOBAL MEDICAL CENTER, INC
SANTA ANA, CA 92704
SANTA ANA, CA 92704
33aNPI1558354258assigned 08/26/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.98M
24GClaims280,241
24DCodes billed146
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#236 of 410
Median peer was paid$6.90M
This provider vs. median0.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official THOMAS, WILLIAM controls 14+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 47,736 | $415K | |
| 2019 | 44,064 | $663K | |
| 2020 | 33,568 | $402K | |
| 2021 | 34,885 | $357K | |
| 2022 | 37,474 | $435K | |
| 2023 | 46,772 | $778K | |
| 2024incomplete | 35,742 | $927K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 13% | 36,650 | 32,747 | $499K |
| A0429 | Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) | 9.0% | 6,272 | 5,117 | $358K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 7.9% | 6,854 | 6,112 | $314K |
| Z7502 | 6.7% | 7,004 | 6,867 | $265K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 5.5% | 4,973 | 4,079 | $217K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 5.2% | 2,292 | 2,103 | $209K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.4% | 2,962 | 2,762 | $174K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.8% | 767 | 713 | $150K |
| 80053 | Comprehensive metabolic panel | 3.0% | 15,688 | 14,180 | $121K |
| 96375 | Therapeutic injection; each additional sequential IV push | 3.0% | 4,587 | 3,953 | $119K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.9% | 17,942 | 16,048 | $117K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.9% | 7,844 | 7,082 | $114K |
134 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.8% | 5,724 | $110K |
| J3490 | Unclassified drugs | 1.9% | 13,171 | $77K |
| 99199 | Unlisted special service, procedure or report | 1.9% | 1,351 | $74K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.8% | 1,574 | $71K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.7% | 4,273 | $68K |
| 71045 | Radiologic examination, chest; single view | 1.4% | 6,464 | $55K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.2% | 1,792 | $49K |
| J7030 | Infusion, normal saline solution , 1000 cc | 1.1% | 7,714 | $46K |
| 0360 | <1% | 2,273 | $37K | |
| 84484 | <1% | 5,053 | $36K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 6,856 | $35K |
| 73630 | <1% | 1,519 | $35K | |
| 83690 | <1% | 6,834 | $34K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 904 | $33K |
| 81025 | <1% | 12,181 | $33K | |
| 83880 | <1% | 1,386 | $30K | |
| 87631 | <1% | 800 | $25K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,510 | $24K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 653 | $23K |
| 83605 | <1% | 2,631 | $21K | |
| Z7500 | <1% | 616 | $21K | |
| 99283 | Emergency room visit (moderate) | <1% | 2,203 | $20K |
| 81001 | <1% | 9,171 | $19K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,681 | $14K |
| 0270 | <1% | 13,668 | $14K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,216 | $13K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,558 | $13K |
| 90715 | <1% | 427 | $11K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 800 | $11K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,667 | $10K |
| 0710 | <1% | 1,517 | $10K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,784 | $10K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 186 | $10K |
| Z9725 | <1% | 217 | $9K | |
| Z7610 | <1% | 878 | $9K | |
| 73610 | <1% | 578 | $9K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 332 | $8K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,084 | $7K |
| 83735 | <1% | 1,426 | $7K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,153 | $7K |
| 82948 | <1% | 2,433 | $7K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 767 | $7K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 76 | $6K |
| 87040 | <1% | 747 | $6K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 128 | $6K |
| J2704 | Injection, propofol, 10 mg | <1% | 1,424 | $6K |
| 85610 | <1% | 2,287 | $6K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 154 | $6K |
| 85027 | <1% | 1,015 | $6K | |
| 73564 | <1% | 274 | $5K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 370 | $5K |
| 85730 | <1% | 1,344 | $5K | |
| 82150 | <1% | 1,146 | $4K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,034 | $4K |
| 59025 | Fetal non-stress test | <1% | 223 | $4K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 382 | $4K |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 375 | $4K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 872 | $4K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 376 | $4K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 903 | $3K |
| 87186 | <1% | 458 | $3K | |
| 76801 | <1% | 84 | $3K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 716 | $3K |
| 99284 | Emergency room visit (serious) | <1% | 233 | $3K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 289 | $3K |
| 84702 | <1% | 494 | $3K | |
| 86900 | <1% | 1,176 | $3K | |
| 87650 | <1% | 230 | $3K | |
| 73130 | <1% | 165 | $2K | |
| 86901 | <1% | 1,178 | $2K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 66 | $2K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 621 | $2K |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 237 | $2K |
| 85380 | <1% | 512 | $2K | |
| 80305 | <1% | 182 | $2K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 24 | $2K |
| 84703 | <1% | 738 | $2K | |
| 88304 | <1% | 211 | $2K | |
| 82550 | <1% | 445 | $2K | |
| 94664 | <1% | 319 | $2K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 302 | $2K |
| J2060 | Injection, lorazepam, 2 mg | <1% | 326 | $1K |
| 0160 | <1% | 43 | $1K | |
| 73030 | <1% | 39 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 94 | $1K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 26 | $1K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 18 | $1K |
| 86850 | <1% | 361 | $949.32 | |
| 0250 | <1% | 703 | $929.08 | |
| 73110 | <1% | 69 | $843.95 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 17 | $711.93 |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 16 | $671.95 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 133 | $619.69 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 28 | $613.86 |
| 93971 | <1% | 13 | $611.28 | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 12 | $576.00 |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 57 | $541.22 |
| 87077 | <1% | 60 | $534.81 | |
| 81003 | <1% | 269 | $503.53 | |
| 0300 | <1% | 1,016 | $447.65 | |
| A4217 | Sterile water/saline, 500 ml | <1% | 66 | $375.76 |
| 74018 | <1% | 38 | $358.16 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 75 | $312.78 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 88 | $298.77 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 34 | $258.77 |
| 72100 | <1% | 13 | $250.29 | |
| 12001 | <1% | 32 | $216.00 | |
| 96376 | <1% | 15 | $182.15 | |
| 0762 | <1% | 246 | $175.41 | |
| 12011 | <1% | 14 | $144.00 | |
| 0100U | <1% | 97 | $137.39 | |
| 87070 | <1% | 17 | $134.54 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,534 | $77.38 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 12 | $69.52 |
| 29125 | <1% | 37 | $65.00 | |
| 71010 | <1% | 12 | $59.56 | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 15 | $52.05 |
| 87420 | <1% | 15 | $36.81 | |
| 99285 | Emergency room visit (most serious) | <1% | 14 | $11.14 |
| 99001 | <1% | 761 | $11.02 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 112 | $6.94 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 33 | $3.28 |
| 0260 | 0% | 125 | $0.00 | |
| 0760 | 0% | 352 | $0.00 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 0% | 82 | $0.00 |
| 0351 | 0% | 15 | $0.00 | |
| 0402 | 0% | 31 | $0.00 | |
| 0320 | 0% | 57 | $0.00 | |
| 0272 | 0% | 16 | $0.00 | |
| 80329 | 0% | 78 | $0.00 | |
| 0324 | 0% | 77 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 12 | $0.00 |
| 0636 | 0% | 133 | $0.00 | |
| 0352 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTHOMAS, WILLIAM (OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Trusted Nurse Staffing | Buffalo, NY | $85.30M |
| KPC Global Medical Centers, INC. | Hemet, CA | $29.34M |
| Victor Valley Hospital Acquisition, INC. | Victorville, CA | $26.63M |
| KPC Global Medical Centers, INC. | Sun City, CA | $8.91M |
| Orange County Global Medical Center, INC | Santa Ana, CA | $8.60M |
| Pediatric and Adolescent Dentistry, LLC | Birmingham, AL | $5.29M |
| South Coast Global Medical Center, INC | Santa Ana, CA | $4.53M |
| Anaheim Global Medical Center, INC | Anaheim, CA | $4.29M |
| Chapman Global Medical Center, INC | Orange, CA | $2.92M |
| Chapman Global Medical Center, INC | Orange, CA | $761K |
| New Creek Family Medicine PLLC | Keyser, WV | $580K |
| Delaware Neurology Associates,pa | Lewes, DE | $75K |
| Anaheim Global Medical Center, INC | Anaheim, CA | $20K |
| Orange County Global Medical Center, INC | Santa Ana, CA | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.